UAE Approves Use Of COVID-19 Vaccine For Front-Line Workers

by Yogita Chainani
UAE Approves Use Of COVID-19 Vaccine For Front-Line Workers

The UAE government on Monday announced the approval of Covid-19 vaccines for front-line workers. Abdul Rahman Al Owais, Minister of Health and Prevention, said the findings of studies during the concluding stages of phase III clinical trials show that the vaccine is useful and has a strong response, producing antibodies to the virus. On the safety of the virus for the citizens, the minister says that the vaccine’s surety is taken into consideration, and the results state that it is safe for use.

Also read: Dubai Economy Shuts A Restaurant In Dubai’s Blue Waters Area For Flouting Covid-19 Protocol

Vaccine Approved Only For Frontline Health Workers 

The National Emergency, Crisis and Disaster Management Authority (NCEMA) announced on Twitter that The Ministry of Health and Prevention (MOHAP) had approved this decision.

Also read: 4 Passengers Are Now Allowed In Taxi Vans In Dubai

In terms of Vaccine, for the time being, it is going to be available for the frontline health workers. Since they are at the highest risk of contracting the virus. This decision will make sure to protect them from dangers and improve safety. The approval is ‘fully aligned with regulations and laws which permit accelerated authorization process’, the authorities say.

Also read: UAE Health Ministry Confirms There Will Be No Lockdown Or Curfew Amid The Rising Covid-19 Cases

Beacon Of Hope For UAE As Covid-19 Vaccine Gets A Nod  

Speaking about this, Dr Nawal Al-Kaabi, Chairperson of the National Clinical Committee for Coronavirus and the principal investigator of the third phase of trials of the inactive vaccine to combat COVID-19, said,

Around 31,000 people from 125 countries were a part of the clinical trials. Conducted over six weeks, 1,000 volunteers were a part of the trials. These volunteers suffered from chronic diseases. On that note, here’s a Full List Of Updated Fines In The UAE. 

Speaking more about the trials, she said.

“The preliminary results are encouraging, however, studies will continue. Side effects are simple and come as expected just like any other vaccine. As of now, no reports of dangerous side effects or symptoms have come into play. “